FOGAR, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.357
AS - Asia 5.694
EU - Europa 3.542
AF - Africa 1.259
SA - Sud America 1.194
OC - Oceania 138
Continente sconosciuto - Info sul continente non disponibili 71
Totale 24.255
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.693
SG - Singapore 2.209
CN - Cina 1.158
BR - Brasile 761
HK - Hong Kong 678
PL - Polonia 443
FI - Finlandia 406
DE - Germania 352
IT - Italia 334
VN - Vietnam 317
SE - Svezia 286
UA - Ucraina 196
RU - Federazione Russa 167
FR - Francia 161
NL - Olanda 140
GB - Regno Unito 130
AR - Argentina 83
IN - India 81
KR - Corea 76
MX - Messico 71
TR - Turchia 63
IQ - Iraq 60
CA - Canada 58
JP - Giappone 53
SA - Arabia Saudita 51
ES - Italia 50
EC - Ecuador 49
ID - Indonesia 49
IE - Irlanda 48
AT - Austria 47
ZA - Sudafrica 47
CI - Costa d'Avorio 45
AO - Angola 44
BJ - Benin 44
KZ - Kazakistan 44
PA - Panama 44
BW - Botswana 43
EG - Egitto 43
UG - Uganda 43
CO - Colombia 42
PT - Portogallo 41
PY - Paraguay 41
MD - Moldavia 40
AU - Australia 39
BZ - Belize 39
CL - Cile 39
KH - Cambogia 39
BY - Bielorussia 38
GM - Gambi 38
PE - Perù 38
VE - Venezuela 38
CR - Costa Rica 37
HR - Croazia 37
ML - Mali 37
AE - Emirati Arabi Uniti 36
AZ - Azerbaigian 36
CZ - Repubblica Ceca 36
GT - Guatemala 36
IR - Iran 36
JO - Giordania 36
TN - Tunisia 36
TW - Taiwan 36
BD - Bangladesh 35
BO - Bolivia 35
DJ - Gibuti 35
JM - Giamaica 35
LB - Libano 35
MA - Marocco 35
ME - Montenegro 35
NO - Norvegia 35
NP - Nepal 35
PR - Porto Rico 35
RO - Romania 35
UY - Uruguay 35
YE - Yemen 35
AF - Afghanistan, Repubblica islamica di 34
CV - Capo Verde 34
CY - Cipro 34
LU - Lussemburgo 34
MW - Malawi 34
TJ - Tagikistan 34
AD - Andorra 33
GF - Guiana Francese 33
HU - Ungheria 33
MY - Malesia 33
PH - Filippine 33
PK - Pakistan 33
SN - Senegal 33
TH - Thailandia 33
UZ - Uzbekistan 33
DZ - Algeria 32
GR - Grecia 32
LA - Repubblica Popolare Democratica del Laos 32
SO - Somalia 32
TZ - Tanzania 32
BA - Bosnia-Erzegovina 31
BE - Belgio 31
BG - Bulgaria 31
CG - Congo 31
EE - Estonia 31
Totale 22.809
Salva come PNG Salva come JPEG
Città #
Singapore 1.194
Fairfield 1.086
Chandler 1.084
Woodbridge 1.057
Ashburn 1.042
Ann Arbor 959
Houston 795
Jacksonville 767
Hong Kong 651
Wilmington 541
Cambridge 433
Bytom 390
Seattle 374
Boardman 319
Beijing 305
Santa Clara 273
Princeton 260
Des Moines 207
Medford 198
Helsinki 165
Nanjing 160
Los Angeles 120
Dong Ket 109
Roxbury 106
San Diego 92
Ho Chi Minh City 79
New York 73
São Paulo 70
Munich 69
Guangzhou 63
Nanchang 52
Padova 50
Buffalo 45
Shenyang 45
Abidjan 43
Cotonou 42
Kampala 42
Hanoi 41
Dublin 39
Hebei 39
Panama City 38
Phnom Penh 37
Bamako 36
Chicago 36
Luanda 36
Tianjin 35
Amman 34
Djibouti 34
Andorra la Vella 33
Baku 32
Dakar 32
Changsha 31
Gaborone 31
Lima 31
London 31
Montevideo 31
Redondo Beach 31
Dushanbe 30
Jiaxing 30
Lusaka 30
Tashkent 30
Antananarivo 29
Harare 29
Hefei 29
Managua 29
Podgorica 29
Ulan Bator 29
Praia 28
Vienna 28
Bishkek 27
Niamey 27
San José 27
Vientiane 27
Conakry 26
Dar es Salaam 26
Milan 26
Yerevan 26
Jinan 25
Lilongwe 25
Nouakchott 25
Tallinn 25
Brooklyn 24
Castries 24
Chisinau 24
Dallas 24
Minsk 24
Norwalk 24
Warsaw 24
Guayaquil 23
Nairobi 23
Noumea 23
Riga 23
Accra 22
Bridgetown 22
Guatemala City 22
Jeddah 22
Johannesburg 22
Zhengzhou 22
Baghdad 21
Banjul 21
Totale 15.144
Salva come PNG Salva come JPEG
Nome #
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 247
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma 246
Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success. 225
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 213
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 208
Alterations in bilirubin metabolism during extra- and intrahepatic cholestasis. 198
ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications 192
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 186
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 182
Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications 178
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 178
Does serum CAR-3 play a role in pancreatic cancer diagnosis? 177
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 174
Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals 173
Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects 173
Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: Which is clinically effective and when? 171
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 170
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 170
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 170
IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. 168
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 166
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging 165
Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases. 164
Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model 163
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation 163
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. 162
In situ analysis of human menin in normal and neoplastic pancreatic tissues: Evidence for differential expression in exocrine and endocrine cells 159
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides 158
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 158
CD44v10: an antimetastatic membrane glycoprotein for pancreatic cancer 158
Clinical utility of TPS, TPA and CA19-9 measurement in pancreatic cancer 158
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 157
Helicobacter pylori infection in children and adults: a single pathogen but different pathology 157
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 156
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 152
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 152
Effect of CagA status on the sensitivity of enzyme immunoassay in diagnosis Helicobacter pylori-infected children 149
Oxygen derived free radicals in patients with chronic pancreatic and other digestive diseases. 149
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 148
Helicobacter pylori virulence genes and host IL-1RN and IL-1b genes interplay in favoring the development of peptic ulcer and intestinal metaplasia 148
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 148
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 148
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 145
Mucopolysaccharidosis type VII diagnosed from a peripheral blood smear 141
Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. 139
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging 138
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome 138
Urinary phospholipase A2 excretion in chronic pancreatic diseases 138
Quantitative PSA mRNA determination in blood: A biochemical tool for scoring localized prostate cancer 137
Cystic Fluid Total Proteins, Low-Density Lipoprotein Cholesterol, Lipid Metabolites, and Lymphocytes: Worrisome Biomarkers for Intraductal Papillary Mucinous Neoplasms 136
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 136
Biological variability of lymphocyte subsets of human adults’ blood 136
Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases. 134
Comparison of two newly identified tumor markers (CAR-3 and DU-PAN-2) with CA 19-9 in patients with pancreatic cancer. 133
Urinary kallikrein excretion in chronic pancreatic diseases. 132
VKORC1, CYP2C9 AND CYP4F2 GENETIC BASED ALGORITHM FOR WARFARIN DOSING. PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN STUDY 130
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 130
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 130
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 129
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 128
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 128
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 127
Interferon gamma (IFNg) and interleukin-10 (IL-10) Haplotypes differently influence Helicobacter pylori infection outcome 126
Suicide gene therapy with the yeast fusion gene Cytosine Deaminase/Uracil Phosphoribosyltransferase is not enough for pancreatic cancer 125
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 125
Carcinogenetic potential of the WSR cagA region. 125
Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19 125
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 123
Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. 122
Neonatal lymphocyte subpopulations analysis and maternal preterm premature rupture of membranes: A pilot study 122
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 121
Carcinogenetic potential of the WSR cagA region of Helicobacter pylori. 121
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 121
Tumor markers in the diagnosis, monitoring and therapy of pancreatic cancer: state of the art. 121
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 120
Beta-cell function in pancreatic adenocarcinoma. 120
Modulazione termica dell'espressione della subunità  catalitica della tossina difterica e delle sue varianti CRM176 e CRM197 nella terapia genica del carcinoma del pancreas 120
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 119
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 119
Pancreatic cancer associated diabetogeni peptide induces nitric oxide synthesis in rat hepathocytes 118
SMAD-4 related and unrelated soluble factors and exosomes co-operate in determining pancreatic adenocarcinoma (PDAC) immunoevasion 117
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 117
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 117
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 116
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 116
Pancreatic cancer gene therapy with diphteria toxin A (DTA) and its variants CRM176 and CRM197. 116
T Cell Senescence by Extensive Phenotyping: An Emerging Feature of COVID-19 Severity 115
NT-S100A8 effects on cell signalling. 115
[Biochemical markers of gastric functioning]. 115
Retrovirus-mediated herpes simplex virus thymidine kinase gene transfer in pancreatic cancer cell lines: an incomplete antitumor effect 115
Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblast: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle gene 114
CAR-3 and CA 19-9 serum levels in pancreatic cancer: any differences between two epitopes of the same mucin-like glycoprotein? 114
Analogues of vitamin E epitomised by alpha-tochopherol succinate (alpha-TOS) for pancreatic cancer treatment: in vitro results induce caution for in vivo applications 114
K-ras point mutations detection in pancreatic cancer serum and bile-derived DNA. 114
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 113
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 110
Gene therapy with HSV-TK: A promising tool for pancreatic cancer treatment? 110
Carcinogenetic potential of the WSR CagA region of Helicobacter pylori 109
Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer. 109
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 109
Totale 14.390
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.854
article - articoli 32.825
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.679
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.140 0 0 0 0 85 109 21 151 210 170 197 197
2021/20221.871 27 368 146 82 60 161 50 143 89 31 185 529
2022/20232.282 438 260 26 267 387 363 8 122 275 26 81 29
2023/20241.088 42 136 111 75 68 176 71 97 27 56 101 128
2024/20254.716 22 234 259 207 652 100 186 291 465 176 877 1.247
2025/20267.137 668 1.468 2.220 2.091 690 0 0 0 0 0 0 0
Totale 24.324